Status:
SUSPENDED
Persistent Atrial Fibrillation Ablation Trial
Lead Sponsor:
Neil Sulke
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Persistent atrial fibrillation (AF) is a common and distressing condition, that can cause significant symptoms. AF ablation is a recognised technique to treat persistent AF, but can be technically dif...
Eligibility Criteria
Inclusion
- Symptomatic persistent or long-standing AF suitable for AF ablation.
- Age over 18 years old.
- Informed consent to participate in this study.
Exclusion
- Pre-existing ILRs or permanent pacemakers that do not allow for continuous monitoring for AF occurrence, or are not MRI-safe.
- Unable to undergo general anaesthesia for AF ablation.
- Previous cardiac surgery, such as coronary artery bypass grafting or valvular surgery.
- Scheduled for elective cardiac surgery, such as coronary artery bypass grafting or valvular surgery.
- Previous thoracic surgery.
- Participation in a conflicting study.
- Potential participants who are mentally incapacitated and cannot consent or comply with follow-up
- Pregnancy
- Other cardiac rhythm disorders
Key Trial Info
Start Date :
September 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2016
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT01891825
Start Date
September 1 2014
End Date
September 1 2016
Last Update
June 26 2014
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Eastbourne General Hospital
Eastbourne, E Sussex, United Kingdom, BN21 2UD
2
Royal Sussex County Hospital
Brighton, East Sussex, United Kingdom, BN2 5BE